About this trial
Prospective, randomized, controlled, single-center pilot study evaluating the feasibility and safety of augmented reality-based remote technical support using the Microsoft HoloLens and EnSite™ Connected Care compared with conventional on-site support during 3D electroanatomical mapping-guided electrophysiological procedures. The study also assesses the feasibility of an AI-based algorithm integrated into the Medinbox Link system for automated procedural report generation and detection of protocol deviations from standard clinical practice.
Eligibility criteria
Qualifiers
Patients age ≥ 18 years
Indication for 3D electroanatomical mapping-based catheter ablation for the treatment of AF
Signed written informed consent
Disqualifiers
Patient is unable or unwilling to provide informed consent
Patient is included in another randomised clinical trial
Inability to comply with the study procedures
Trial design
Treatments tested in this trial
- HoloLens supported catheter ablation
- On-site supported catheter ablation